SEP 9, 2026 · PHASE 2 TRIAL
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov
Phase 2 trial in a vulnerable population with immunosuppression; registry record reports no results, only planned design and enrollment completion.
Reported
Enrollment (actual)47
Study phasePHASE 2
Primary outcome measureT cell response, Baseline to day 56